There are potent immunomodulators in saliva of the bloodfeeding arthropods which transmit many of the world's most serious diseases that may bene®t the arthropod by preventing the vertebrate host from becoming sensitized to the saliva. In addition, saliva can enhance transmission of parasites/pathogens by arthropods. As a result, vaccines that target the arthropod (e.g. salivary immunomodulators) should be considered as one component of multisubunit vaccines against arthropod-borne parasites/pathogens. Indeed, since vaccines against the pathogens themselves are often not fully protective, vaccines that target several facets of the life cycle of the pathogen may be the most effective at controlling disease transmission. This review covers known immunomodulatory factors in arthropod vector saliva, focusing mainly on sand¯ies and ixodid ticks.
INTRODUCTION
Within the realm of parasitism, bloodfeeding ectoparasitic arthropods would appear to have a formidable set of obstacles to circumvent in their quest for a bloodmeal. For example, vertebrates have developed several sophisticated and redundant mechanisms for preventing blood loss; yet, bloodfeeding arthropods (which can require blood for nutrition, egg production and survival) have evolved equally powerful methods for bypassing these haemostatic mechanisms. In addition to the need to circumvent haemostatic mechanisms, bloodfeeding arthropods must also combat host in¯ammatory/immune counter-attacks. For example, ticks feed for an extended period (3±10 days) on the vertebrate host, and they, or their offspring, can later return to feed on the same host, yet, in certain cases, the host does not appear to mount an effective in¯ammatory/ immune response to the feeding ticks (Ribeiro 1987a , Randolph & Nuttall 1994 , Wikel 1996 , Brossard & Wikel 1997 , Nuttall 1998 .
Bloodfeeding ectoparasitic arthropods inject their saliva when they probe for a bloodmeal. This saliva contains a number of molecules including proteins, enzymes, prostaglandins, etc. (Ribeiro 1987a , 1995 , Champagne 1994 , Bowman et al. 1996 , Stark & James 1996b , Bowman et al. 1997 . The thesis of this review is that bloodfeeding arthropods have evolved salivary immunomodulatory factors that: (1) prevent the vertebrate host from rejecting the arthropod and/or becoming sensitized to the vaso-modulatory proteins/ factors of saliva that facilitate bloodfeeding and (2) inadvertently enhance pathogen transmission by arthropods. Indeed, the pathogens that cause many of the world's most common infectious diseases, ranging from malaria, ®laria-sis, trypanosomiasis and leishmaniasis to Lyme disease, are transmitted by bloodfeeding arthropod vectors such as mosquitoes, tsetse¯ies, sand¯ies and ticks (Beaty & Marquardt 1996) . In studies conducted using experimental animal models for these diseases, infections are routinely initiated by injecting the pathogens via syringe. However, it is now evident that bloodfeeding arthropod vectors are not simplỳ¯y ing or crawling syringes.' Rather, arthropod saliva, which is often coinjected with the pathogens, is known to contain several powerful factors that suppress host in¯ammatory/ immune responses. Therefore, administering pathogens to animals by way of syringe does not mimic natural disease transmission (Randolph & Nuttall 1994) .
This review will focus primarily on sand¯ies and ticks as two examples of how arthropod vector saliva is immunomodulatory and may enhance transmission of pathogens by arthropod vectors. For information on other vectors, refer to Table 1 and to the several pertinent sources cited therein. In addition, while some antihemostatic vector salivary components may be considered to be immunomodulatory, some are probably not. Thus, due to the limited scope of this review, only some of the former will be covered; however, there are several reviews that provide a more complete treatment of the pharmacological activities of arthropod saliva (Champagne 1994 , Ribeiro 1995 , Champagne & Valenzuela 1996 , Stark & James 1996b , Bowman et al. 1997 .
Certain of the salivary activities listed in Table 1 are common to all of the vectors; these are in¯ammation inhibitors, cytokine modulators and anti-coagulants. It is apparent how in¯ammation inhibitors and cytokine modulators might prevent the vertebrate host from becoming sensitized to the feeding arthropod and might also enhance pathogen transmission by the arthropod. In¯ammation is a common feature of an immune response and cytokines are one of the principal mediators of such a response. Anticoagulants may also inhibit the development of an immune response. For example, simulidin from the black¯y Simulium vittatum is an anti-coagulant that inhibits a-thrombin, and a-thrombin is chemotactic for immune cells such as macrophages (Abebe et al. 1995) . The thrombin inhibitors anophelin and americanin have also been cloned, respectively, from the mosquito, Anopheles albimanus (Francischetti et al. 1999 ) and the tick Amblyomma americanum (Zhu et al. 1997a) . As with anti-coagulants, it may not be Ribeiro et al. 1984 , Ribeiro et al. 1985b , Cupp et al. 1994 , Stark & James 1995 , 1996a , 1998 , Francischetti et al. 1999 Brossard , Bowman et al. 1997  o Wikel et al. 1978 , Wikel & Osburn 1982 , Ribeiro et al. 1985 , Urioste et al. 1994 , Ramachandra & Wikel 1992 , 1995 , Fuchsberger et al. 1995 , Ferreira & Silva 1998 p Wikel 1985 , Fivaz 1989 q Ramachandra et al. 1992 , 1995 , Urioste et al. 1994 , Ferreira et al. 1998 Ribeiro et al. 1985a , Ribeiro 1987b , Ramachandra et al. 1992 , 1995 u Ribeiro et al. 1985a , Ramachandra et al. 1992 , 1995 , Borsky et al. 1994 , Urioste et al. 1994 , Ganapamo et al. 1995 , 1996a ,b, Fuchsberger et al. 1995 , Zeidner et al. 1997 , Ferreira et al. 1998 v Ribeiro 1987b , Zhu et al. 1997a , 1997b  w Ribeiro et al. 1985a , Bowman et al. 1996 , Champagne 1994  x Paesen et al. (Ribeiro 1987b) , anaphylatoxin inactivator (Ribeiro & Spielman 1986 ) and immunoglobulin binding protein (Wang & Nuttall 1994 , 1995 , Wang et al. 1998 . It is again apparent how these factors might in¯uence an in¯ammatory/immune response since histamine, complement, anaphylaxis and immunoglobulins can play a central role in the development of an in¯ammatory/immune response. The rationale for focusing on sand¯ies (vectors of Leishmania and other pathogens) and ixodid ticks (vectors of many classes of pathogens) in this review is that these arthropods are at opposite ends of the`feeding spectrum'. That is, sand¯ies feed rapidly but hundreds of¯ies can bite the host each day, whereas, ticks feed slowly, attaching to hosts for 3±10 days, and can return to feed on the same host. Therefore, both arthropods must prevent sensitization of their host to their salivary proteins. However, because of their different feeding habits, these arthropods may have evolved markedly different salivary proteins that immunosuppress the host by different mechanisms.
SANDFLIES AND LEISHMANIASIS
Protozoan parasites of the genus Leishmania are found in their infectious¯agellated promastigote form in the gut of the phlebotomine sand¯y, the vector for the parasite. When the sand¯y probes for a bloodmeal on a mammalian host, it injects promastigotes within its saliva. These parasites are engulfed by phagocytic cells in which they transform into their amastigote form. The phlebotomine sand¯y can transmit different species of Leishmania that can induce different clinical forms of leishmaniasis in humans, ranging from cutaneous forms (caused by Leishmania major, Leishmania mexicana or Leishmania braziliensis) to dis®guring mucocutaneous (L. braziliensis) or lethal visceral (Leishmania donovani) disease (Neva & Sacks 1990 ).
Salivary gland lysates of New World sand¯ies (Lutzomyia longipalpis) enhance infection with Leishmania
To induce infection with L. major in experimental mice, investigators commonly inject millions of parasites by syringe. In contrast, the sand¯y injects only 1±100 parasites (Warburg & Schlein 1986) . Why is the sand¯y so much more ef®cient than the syringe? In addition, how does this low number of parasites survive the host's defense mechanisms to cause disease? Since L. major is injected by the sand¯y within its saliva, it is possible that a component(s) of saliva somehow protects the parasite and thus augments its infectivity for the host. To test this possibility, experiments were performed in which mice were infected with L. major in the presence or absence of sand¯y (Lutzomyia longipalpis) salivary gland lysate to determine whether the presence of saliva enhanced the infectivity of L. major for mice (Titus & Ribeiro 1988) . It was found that in addition to enhancing lesion size, sand¯y salivary gland lysate also markedly enhanced the parasite burden within the lesions. In some cases, the parasite burden in saliva-treated lesions was 5580-fold greater than the parasite burden found in control (saliva-free) lesions (Titus & Ribeiro 1988) . Since the initial work with L. major, it has been shown that sand¯y saliva exacerbates infection with all species of Leishmania tested (Samuelson et al. 1991 , Theodos et al. 1991 , Warburg et al. 1994 , Lima & Titus 1996 . The most striking results are obtained with L. braziliensis; and representative results are given in Figure 1 . L. braziliensis alone induces only a transient infection in mice. In contrast, when the parasite is coinjected with L. longipalpis saliva, the lesions do not Figure 1 Sand¯y salivary gland lysate reverses the outcome of infection with Leishmania braziliensis in mice. BALB/c mice were injected with either 1´10 6 L. braziliensis (WR 604) or L. braziliensis the lysate of 0.5 salivary gland of L. longipalpis. Lesion size was followed by measuring the increase in size of the infected footpad compared to the size of the contralateral control footpad. At day 90 of infection, duplicate mice in each group were assessed for the numbers of parasites present in the lesions using techniques described previously (Lima et al. 1997). resolve resulting in enormous parasite burdens compared to control (saliva-free) mice (Figure 1) . Indeed, lesions persist on saliva-treated mice for the lifetime of the animals (Samuelson et al. 1991 , Lima & Titus 1996 . Therefore, sand¯y saliva reverses the outcome of infection with L. braziliensis in mice.
What factor in saliva is responsible for its effects, and what is the mechanism of action of this molecule? Initially, it was proposed that the vasodilatory and disease-enhancing capacities of saliva might be mediated by a single peptide in saliva and that this salivary peptide might be related to mammalian neuropeptides (Nong et al. 1989 , Ribeiro et al. 1989 , Titus & Ribeiro 1990 ). Neuropeptides can also be both vaso-as well as immunomodulatory (Nong et al. 1989 , Titus & Ribeiro 1990 . Therefore, the gene that encodes the vasodilatory peptide present in sand¯y salivary glands was cloned (Lerner & Shoemaker 1992) . The peptide product of this gene was termed maxadilan, or MAX (Lerner et al. 1991) . When injected into the skin, recombinant MAX induced long-lasting erythema which had the same characteristics and was equivalent to the erythema obtained following (1) injection of native MAX puri®ed from whole saliva, (2) injection of whole saliva, or (3) the bite of a sand¯y (Ribeiro et al. 1989 , Lerner et al. 1991 . Thus, MAX appears to be the principal vasodilator in sand¯y saliva, and MAX is injected by sand¯ies when they probe in the skin for a bloodmeal.
It has been found that the primary amino acid sequence of MAX is polymorphic (Lanzaro et al. 1999) . For example, comparing the sequences of MAX isolated from Brazilian or Colombian L. longipalpis, there are as many as 13 amino acid substitutions in this 63 amino acid peptide. Interestingly, despite this polymorphism, the functions (e.g. vasodilation) of the different MAX molecules appear to not be altered (Lanzaro et al. 1999) . It has been suggested that this primary sequence¯uidity of MAX may represent an attempt by the sand¯y to optimize the potency of MAX for a given host while preventing the host from becoming sensitized to MAX and thus to sand¯y bites (Lanzaro et al. 1999) . In all of the experiments described in this review, synthetic or recombinant MAX based on the Brazilian (Lapinha Cave) MAX sequence (Lanzaro et al. 1999) was used.
To test whether MAX would also be an immunomodulator and thus enhance infection with L. major in mice, synthetic MAX (3 ng; approximately the amount of MAX in the lysate of 0´5 sand¯y salivary gland, Lerner et al. 1991) was coinjected with L. major (1´10 5 ) into the footpads of mice. MAX exacerbated lesion size and parasite burden within the lesions to the same degree as the coinjection of 1´10 5 L. major with the lysate of 0´5 sand¯y salivary gland (Mbow et al., unpublished). Thus, MAX appears to be the principal peptide in sand¯y saliva that mediates vasodilation À bene®cial to the¯y since this would enhance blood¯ow and thus hasten the completion of a bloodmeal for the¯y. In addition, MAX appears to be the principal peptide in sand¯y saliva that enhances infection with L. major À bene®cial for the parasite and presumably for the¯y as well since MAX should inhibit the development of an immune response to other proteins present in sand¯y saliva. However, the existence of other immunomodulators in the saliva of L. longipalpis has not been fully investigated. Indeed, the likely biochemical complexity of L. longipalpis saliva has recently been demonstrated in a report of nine salivary gland-speci®c cDNA clones, ®ve of which are possibly associated with bloodmeal acquisition (Charlab et al. 1999) .
The known immunomodulatory activities of whole sandy saliva and MAX are summarized in Table 2 . Saliva and MAX both inhibit the functions of T cells and macrophages; however, the effect on T cells is mediated indirectly through macrophages (Theodos & Titus 1993) . Thus, an important target cell for MAX is the macrophage (the principal host Table 2 Known immunomodulatory effects of sand¯y salivary gland lysate and maxadilan
Saliva Maxadilan
Exacerbation of leishmaniasis (Titus et al. 1988) Exacerbation of leishmaniasis (Mbow et al., unpublished) Inhibition of T cell activation (Theodos et al. 1993 , Titus 1998 ) Inhibition of T cell activation (Qureshi et al. 1996) Inhibition of delayed-type hypersensitivity (Qureshi et al. 1996) Inhibition of H 2 O 2 production by macrophages (Table 3) Inhibition of nitric oxide production by macrophages Inhibition of nitric oxide production by macrophages (Mbow et al., unpublished) (Hall et al. 1995 , Waitumbi & Warburg 1998 cell for L. major), and MAX has several effects on macrophages that would explain its ability to exacerbate infection with L. major in mice and to prolong the survival of the parasite in the host. MAX inhibits the production of nitric oxide, H 2 O 2 and TNF-a by macrophages (Table 2) , and all of these factors are associated with killing of Leishmania by the cells (reviewed in Titus et al. 1994) . In contrast, MAX augments the production of interleukin (IL)-10, prostaglandin E (PGE) 2 and IL-6 (Table 2 ), all of which should enhance survival of L. major. IL-10 negatively regulates interferon (IFN)-g production and can inhibit nitric oxide production by macrophages (Cunha et al. 1992 , Moore et al. 1993 . Decreased IFN-g and nitric oxide production should be bene®cial for L. major since IFN-g activates macrophages to kill L. major through its ability to elicit nitric oxide production by the cells . PGE 2 inhibits in¯ammation, favours the outgrowth of IL-4-producing cells (Phipps et al. 1991) , and has been shown to lead to progression of infection in mice infected with L. major (Farrell & Kirkpatrick 1987 , de Freitas et al. 1999 . In addition, IL-6 can favour the outgrowth of IL-4-producing cells (Rincon et al. 1997) . Enhanced production of IL-4 should also be bene®cial for L. major since IL-4 can exacerbate infection with Leishmania and can block destruction of Leishmania within macrophages . Taken as a whole, these numerous effects of MAX on macrophages may be suf®cient to explain the exacerbative effect that MAX (and possibly whole sand¯y saliva) has on infection with L. major.
Finally, the receptor through which MAX mediates its effects is the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor (Moro & Lerner 1997 , Bozza et al. 1998 , Soares et al. 1998 . The PACAP receptor is expressed by macrophages, and PACAP has the same effects as MAX on macrophages. Moreover, PACAP antagonists block the actions of MAX on macrophages (Soares et al. 1998) . Interestingly, PACAP itself is similar to MAX [although the two have little sequence similarity (Moro et al. 1997) ] in that PACAP also is both vasoactive and immunomodulatory (Tatsuno et al. 1991a , 1991b , Arimura 1992 , Christophe 1993 , Desai & Burrin 1994 , Gottschall et al. 1994 , Martinez et al. 1996 . Therefore, L. longipalpis sand¯ies have evolved a salivary peptide (MAX) which is a PACAP analogue and which appears to mediate all of its immunosuppressive effects through interaction with macrophages.
Salivary gland lysates of Old World sand¯ies (Phlebotomus papatasi) also enhance infection with Leishmania
A homologue of MAX has not been identi®ed in the saliva of Phlebotomus papatasi sand¯ies. Therefore, apyrase may be the principal vaso-modulatory molecule present in P. papatasi saliva (Ribeiro 1987a , Ribeiro et al. 1989 , Champagne 1994 . If there is not a MAX homologue in P. papatasi saliva, this does not exclude the possibility that there are other immunomodulatory molecules present in P. papatasi saliva. To test this possibility, salivary gland lysates of P. papatasi [a sand¯y that transmits L. major in nature (Adler et al. 1928 , Grimaldi & Tesh 1993 ] were coinjected with L. major into mice. These salivary gland lysates also markedly enhanced the development of cutaneous lesions of L. major and the burden of parasites within those lesions (Theodos et al. 1991 , Belkaid et al. 1998 , Mbow et al. 1998 .
In an effort to determine the mechanism underlying the exacerbative effect of P. papatasi saliva on infection with L. major, the production of various cytokines and nitric oxide by mice infected with either parasites alone or parasites plus saliva was measured. Saliva inhibited the production of protective type 1 cytokines and factors such as IFN-g, IL-12 and nitric oxide while it enhanced the production of the exacerbative cytokine, IL-4 (Mbow et al. 1998 , Belkaid et al. 1998 . Interestingly, P. papatasi saliva enhanced Human macrophages were pre-treated with sand¯y salivary gland lysate (L. longipalpis) or with medium for 3 h, the salivary material was washed away and the cells were activated with IFN-g (200 U/ml). Three days later, H 2 O 2 produced by the cells in response to IFN-g was determined using techniques described in Nong et al. (1989) IL-4 mRNA expression when it was injected into mice in the absence of L. major (Mbow et al. 1998 ). This ability of P. papatasi saliva to upregulate the production of IL-4 probably explains its ability to exacerbate infection with L. major since, as discussed above, IL-4 can exacerbate infection with Leishmania and can block destruction of Leishmania within macrophages ). It will be interesting to see what is discovered about the nature of the factor(s) in P. papatasi saliva that enhances infection with L. major.
TICKS AND THE MANY DISEASES THEY TRANSMIT
On a worldwide scale, ticks are signi®cant vectors of disease to humans and domestic animals. Studies of many different species of hard ticks have identi®ed diverse immunomodulatory phenomena. When comparing these reports, it appears that many of these immunomodulatory phenomena are common to more than one species of hard tick. This is especially true of the modulation of cytokine production by tick feeding. We have chosen to limit this section mainly to a discussion of the principal North American vector of Lyme disease spirochetes (Burgdorfer et al. 1982) , Ixodes scapularis. In addition to Lyme disease, I. scapularis ticks are vectors of other pathogens that are responsible for rickettsial diseases (Burgdorfer 1977), babesiosis (Spielman et al. 1985 , Piesman et al. 1986 ) emerging infections such as ehrlichiosis (Magnarelli et al. 1995 , Telford et al. 1996 , and may also transmit tick-borne encephalitis viruses (Telford et al. 1997 ), all of which may be in¯uenced by tick salivary immunomodulatory factors. Other tick associated immunomodulatory activities are referred to in the Introduction and Table 1 , as well as in several other excellent reviews (Bowman et al. 1996 , Brossard & Wikel 1997 . The aetiological agent of Lyme disease, Borrelia burgdorferi, develops ®rst in the midgut of the tick. It then migrates to the salivary glands when the tick is taking a bloodmeal and is injected in tick saliva into the vertebrate host (Ribeiro et al. 1987 , Zung et al. 1989 . B. burgdorferi does not migrate away from the tick feeding site until several days after the tick has completed taking its bloodmeal and detached from the host (Shih et al. 1992 , Shih & Spielman 1993 . Although there are alternative explanations for this phenomenon, it is likely that the spirochetes do not migrate because the tick's saliva conditions the host in a way that favours survival of the spirochetes early in the infection. This could be due to anti-in¯ammatory/immunosuppressive factors in saliva.
It seems intuitive that tick saliva contains anti-in¯ammatory/ immunosuppressive factors. In contrast to most bloodfeeding arthropods, ixodid ticks require days to weeks to feed to repletion (Binnington & Kemp 1980) . As a result, certain hosts [especially unnatural ones (Trager 1939 , Davidar et al. 1989 ] are successful in mounting a nonspeci®c [neutrophils surrounding the mouthparts of the feeding tick (Wheeler et al. 1989) ] and even a speci®c [T and B cell (Trager 1939 , Brossard et al. 1982 , Brown 1982 , Wikel 1984 ] anti-tick immune response (Wheeler et al. 1989 , Whelan & Wikel 1993 , Borsky et al. 1994 , Mbow et al. 1994 , Ganapamo et al. 1997 . In fact, this immune response can be directed against components of the salivary gland itself (Wikel 1981 , 1984 , Wheeler et al. 1989 , Ganapamo et al. 1997 . This anti-tick response can decrease the tick's bloodfeeding success and ultimately cause rejection of the tick (as measured by decreased feeding/dropoff weight, fecundity and moulting success). Therefore, to maintain feeding success, hard ticks would appear to require anti-in¯ammatory and immunosuppressive elements in their saliva. In fact, such factors must exist in tick saliva since it has been reported that tick saliva inhibits neutrophil function (Ribeiro et al. 1990 ) and interferes with the complement system (Ribeiro et al. 1986 , Ribeiro 1987b ) in vitro. There is also evidence in vitro for the occurrence of natural killer (NK) cell (Kubes et al. 1994 , Kopecky & Kuthejlova 1998 , and macrophage activity modulators (Ramachandra & Wikel 1992 , 1995 , Urioste et al. 1994 , Ferreira & Silva 1998 . Taken together, these observations suggest that coevolution of ticks, their hosts and the pathogens that ticks transmit may have, in part, been driven by immunosuppressive factors in the tick's saliva (Randolph et al. 1994) . That is, ticks that had these immunosuppressive factors may have been more successful at bloodfeeding, and thus reproduction; and pathogens transmitted by these ticks may have been more successful at infecting the host, thus ensuring their propagation.
What might be the nature of the tick immunosuppressive substance(s)? One hint came with the work of Wikel (Wikel et al. 1978 , Wikel 1982 , Wikel & Osburn 1982 who demonstrated that lymphocytes from tick-infested experimental animals had greatly reduced responses to mitogens in vitro. That is, ticks feeding on the host had a systemic immunosuppressive effect on the host's immune system. This effect has subsequently been demonstrated in vitro using the saliva or salivary gland extracts of several different species of hard ticks (Wikel et al. 1978 , 1982 , Ribeiro et al. 1985a , Ramachandra et al. 1992 , 1995 , Urioste et al. 1994 , Fuchsberger et al. 1995 , Ferreira et al. 1998 . Several authors proposed that PGE 2 in tick saliva was responsible for its immunosuppressive qualities (Ribeiro et al. 1985 , Ramachandra et al. 1992 , Inokuma et al. 1994 . PGE 2 has known effects on the immune system at several levels including the ability to downregulate the functions of T and B cells (Phipps et al. 1991) and macrophages (Bahl et al. 1990 , Spatafora et al. 1990 ). However, PGE 2 is quite labile in vivo; one transit through the pulmonary circulation removes > 95% of its activity (Piper et al. 1970) . Thus, it is unlikely that PGE 2 was responsible for the systemic immunosuppression observed by Wikel. An exception to the above discussion is that since bovine T cells are very sensitive to low PGE 2 concentrations in vitro, the salivary PGE 2 from the cattle tick (Boophilus microplus) is proposed to be suf®cient to produce physiological effects in cattle (Inokuma et al. 1994) . Given the extraordinarily high concentrations of prostaglandins (PGE 2 , PGF 2a and PGI 2 ) in tick saliva, approximately 33±2200 ng/ml for PGE 2 (Bowman et al. 1996) , it is very likely that they would have some effects on the immune system of the host; however, thorough investigations addressing this possibility in speci®c tick-host systems have not been published. Another possibility is that tick prostaglandins serve as vasodilators (Champagne 1994 , Bowman et al. 1996 , a function that would be important at the site of attachment and also probably not affected by its lability.
Several years ago it was demonstrated that the factor in I. scapularis saliva that inhibited lymphocyte proliferation in response to mitogens was a protein and that the phenomenon could not be accounted for by the PGE 2 content of the saliva (Urioste et al. 1994) . Interestingly, subsequent analysis of this phenomenon revealed that the inhibitory effect of saliva could be washed away after preincubation with splenocytes. This suggested that the salivary factor(s) responsible were not interacting directly with the cells and led to the identi®cation in vitro of a putative IL-2 binding factor in the saliva (Gillespie et al. submitted). This activity could supply a mechanism through which tick saliva can modulate T cell activity. Furthermore, it has potentially far reaching effects on the immune system due to the existence of IL-2 receptors on many cell types including B cells, macrophages and NK cells (Siegel et al. 1987 , Smith 1992 , Theze et al. 1996 .
Work with Dermacentor andersoni salivary gland extracts (Bergman et al. 1995) and saliva (Bergman et al. 1998) has shown that a protein of approximately 36 kDa is responsible for suppression of T cell proliferation (Bergman et al. 1995) . The N-terminal sequence of this protein has been obtained and appears to be unique (Bergman et al. 1998); however, it remains to be determined how this protein mediates its effect on T cells.
Many studies have focused on the effects of feeding various species of ixodid ticks on the cytokine expression patterns of various host animals in vitro (Borsky et al. 1994 , Fuchsberger et al. 1995 , ex vivo (Ganapamo et al. 1996a ,b, Zeidner et al. 1997 , Schoeler et al. 1999 ) and in situ (Mbow et al. 1994) . A limited number of studies involving feeding I. scapularis nymphs on mice have also been published, all utilizing ex vivo restimulation of splenocytes. Schoeler et al. (1999) have recently shown that repeated infestations with pathogen-free nymphs on Lyme disease-resistant (BALB/c) and susceptible (C3H/HeN) mice resulted in suppression of the Th1 cytokines IL-2 and IFN-g and enhancement of the Th2 cytokines IL-4 and IL-10, though to different degrees between the two strains of mice (Schoeler et al. 1999) . These results support the observations of Zeidner et al. (1997) who noted the same trends in mouse cytokine expression patterns after a single infestation. Zeidner et al. (1997) also took the additional approach of studying the effects of uninfected nymphs compared to nymphs infected with B. burgdorferi, thus allowing an assessment of the relative contribution of the vector and the pathogen to host immunomodulation. Using infected nymphs, they found that Th2 polarization occurred in C3H/HeJ mice but not in BALB/c mice after a single infestation, as assessed using splenocytes, and they suggested that this might have rami®cations for spirochete transmission in vivo. Indeed, differences in susceptibility of hosts to tick feeding, and likewise pathogen transmission, may lie in relatively subtle differences in cytokine expression following exposure to tick salivary secretions and associated pathogens.
Finally, the possible importance of cytokines in transmission of B. burgdorferi by ticks was examined by experiments in which IFN-g, IL-2 and/or TNF-a were administered to mice and the mice were challenged with infected nymphs (Zeidner et al. 1996) . Both IL-2 and IFN-g downregulation have been identi®ed ex vivo after exposure to feeding of I. scapularis on mice (Zeidner et al. 1997 , Schoeler et al. 1999 . IFN-g production is associated with Th1 type immune responses and induces production of the pro-in¯ammatory cytokine TNF-a by macrophages. Signi®-cant levels of protection from tick-borne B. burgdorferi infection, up to 95% in one formulation, were seen when IFN-g, IL-2 and/or TNF-a were administered to mice in various combinations during the tick challenge. These studies lend support to the general conclusion that feeding by I. scapularis and other hard tick species downregulates a Th1 type response while it upregulates a Th2 type response. However, this effect may depend on the number of infestations a host is exposed to, as an increase in IFN-g production has been documented (ex vivo by restimulation of lymph node cells draining the feeding site and in situ at the tick attachment site and draining lymph nodes) over the course of several infestations with Ixodes ricinus (Mbow et al. 1994 , Ganapamo et al. 1995 . Thus, a model of T cell modulation that explains all of the available data on hard ticks has yet to emerge and it remains to be seen if the above generalization will hold in all tick-host experimental systems. Taken as a whole, these ®ndings also suggest that skewing of the T cell immune response may play an important role in the transmission of B. burgdorferi and other pathogens transmitted by I. scapularis.
SIGNIFICANCE
One of the most important discoveries in vector biology that has emerged over the past two decades is that vector arthropods are not simply`¯ying/crawling syringes'. Immunomodulatory factors are present in the saliva of most if not all bloodfeeding arthropods, thus giving arthropods a much more decisive role in pathogen transmission than simply piercing the skin of the host. In this review, we describe three such factors that target different components of the immune system: macrophages (MAX), IL-4 (P. papatasi saliva) and IL-2 (I. scapularis saliva). These salivary factors may profoundly enhance pathogen transmission. For example, as discussed here, sand¯y saliva or MAX enhances the infectivity of various species of Leishmania for mice. In addition, the group of Nuttall and colleagues have shown that tick saliva enhances transmission of Thogoto (Jones et al. 1989 ) and tick-borne encephalitis (Labuda et al. 1993) viruses, and the group of Beaty and colleagues have shown that feeding mosquitoes enhance the infectivity of Cache Valley virus [Bunyaviridae (Edwards et al. 1998) ]. Indeed, the fact that arthropod saliva can enhance pathogen transmission may be the reason why arthropods transmit so many different kinds of pathogens.
The fact that arthropod saliva can enhance pathogen transmission leads to the interesting possibility that vaccinating the host against the components of vector saliva will inhibit pathogen transmission. Alternatively, since vaccines against pathogens transmitted by arthropods are frequently not fully protective, vector-based vaccines should be considered as one component of multisubunit vaccines against arthropod-borne diseases. One of the most appealing aspects of vector-based vaccines is the possibility that one vaccine against the vector will inhibit transmission of all pathogens delivered by the arthropod when it takes a bloodmeal.
Recent work in our laboratory has shown that when mice are vaccinated against MAX they are protected against a subsequent challenge with L. major plus sand¯y saliva [protection manifested itself as smaller cutaneous lesions of L. major and greatly reduced parasite burdens within those lesions (Mbow et al. unpublished) ]. Since MAX modulates immune functions (Table 2), ef®cient vaccination was not possible with functional MAX; rather, a loss-offunction mutant form of MAX was required. Recent work by Belkaid et al. (1998) also demonstrated that pre-exposing mice to sand¯y saliva protected the mice against the diseaseenhancing effects of saliva when the mice were subsequently coinjected with L. major plus sand¯y saliva. These results con®rm and extend the observations discussed above with MAX-vaccinated mice and suggest that a saliva-based vaccine will be effective.
In addition to these results with sand¯ies, there are several reports in the literature that demonstrate that vector-based vaccines may be effective. For example, infesting guineapigs with pathogen-free Ixodes scapularis ticks confers resistance to a subsequent infection with B. burgdorferi (Lyme disease) delivered by tick bite (Nazario et al. 1998 ). This was not due to the development of an anti-B. burgdorferi immune response in the tick-infested guinea-pigs since these animals had no antibody to B. burgdorferi. A similar study was performed with mice and generated similar results (Wikel et al. 1997a) . Both groups suggested the possibility that an immune response to tick salivary antigens and immunosuppressive factors may have resulted in protection against B. burgdorferi transmission (Wikel et al. 1997a , Nazario et al. 1998 . However, this hypothesis has not yet been tested directly. In addition to that discussed above, host reactivity to vector saliva can modify the course of infection with viruses (Feinsod et al. 1975 , Jones et al. 1989 , and mice can be protected against infection with Plasmodium berghei by immunization with normal mosquito salivary glands (Alger et al. 1972 , Alger & Harant 1976 . Studying the components of vector salivary glands should lead to the description of substances with potent pharmacological and immunological activities that may have therapeutic value. Relatively few organisms bite humans, and fewer still bite to obtain blood. Saliva is critical to the vector's ability to take a bloodmeal, and thus it is believed that considerable coevolution must have occurred between arthropods and mammals (Randolph et al. 1994) . Therefore, the components of saliva and the mechanism by which these factors act should be quite interesting. Finally, analysis of the immunosuppressive factors in vector saliva and the manner through which these substances affect the immune system may lead to a better understanding of immunoregulation in general.
FUTURE DIRECTIONS
The ultimate goal of research that examines pathogens transmitted by arthropods is to develop an effective vaccine against these pathogens. A great deal of work has examined interactions between these pathogens and their vertebrate hosts. This review has summarized some of the work that has focused on interactions which occur between the arthropod and the vertebrate host. To date, this work has identi®ed a number of interesting and potentially useful salivary factors that may be effective as component(s) of subunit vaccines against arthropod-borne diseases. This experimental approach should be intensi®ed and broadened in the future.
The facet of pathogen±vector±vertebrate host interactions that perhaps has received the least attention is the interactions that occur between the pathogen and arthropod.
Yet this experimental approach has also been fruitful and there is every indication that it will contribute to improved methods for controlling arthropod-borne diseases. Some examples of work that has examined the intricate and fascinating interface between pathogen and vector are provided below.
Sand¯ies
Work of the group of Sacks and colleagues has revealed that complex interactions occur between the surface lipophosphoglycan molecule of Leishmania parasites and receptors on the midgut (Pimenta et al. 1992) of sand¯ies. These interactions lead to the development of infective metacyclic forms of the parasite which are injected by the sand¯y into the vertebrate host (Sacks & Perkins 1984) . Recent work utilizing genetically manipulated Leishmania has con®rmed the central role of lipophosphoglycan in parasite/sand¯y interactions (Sacks et al. 2000) .
Ticks
Work by Schwan et al. (Schwan et al. 1995 , Schwan & Piesman 2000 has revealed that B. burgdorferi undergoes changes in expression of important outer surface proteins in the midgut of its tick vector; these changes may be important in the development of virulence of B. burgdorferi for the vertebrate host.
Mosquitoes
Mosquitoes are arguably the most important arthropod vectors of disease, if for no other reason than they transmit malaria À a pathogen that has an enormous impact on human health worldwide. It has been shown that the mosquito can resist infection with the malaria parasite by encapsulating the malaria ookinete after it completes its passage through the mosquito midgut (Collins et al. 1986 ). In addition, infection of mosquitoes with malaria organisms induces several immune markers (Dimopoulos et al. 1998) but, to date, only nitric oxide has been shown to signi®cantly reduce parasite numbers (Luckhart et al. 1998 ). More recently, it was shown that mosquitoes also express several elements of vertebrate speci®c immune responses (BarillasMury et al. 1996 (BarillasMury et al. , 1999 .
It is perhaps not surprising that it has proven dif®cult to develop effective vaccines against vector-borne pathogens/ parasites. These organisms often have very complex life cycles. Moreover, a parasite by de®nition is an organism that lives in or on another organism and often this parasitic existence lasts for the lifetime of both organisms. Therefore, it may be very dif®cult to develop pathogen-based vaccines that are long-lived and that induce sterile immunity to organisms such as Leishmania, Borrelia or the malaria parasite. However, vaccines that target more than one facet of the life cycle of a parasite (e.g. the pathogen itself, vector salivary factors, vector±pathogen interactions) may prove to be very effective. It is the goal of all those who work in these various areas of research to develop such vaccines. In order to pursue this goal, a more thorough understanding of the biological processes occurring at host± vector±parasite interfaces and their molecular mediators is necessary. Efforts to date have provided a tantalizing glimpse of what may eventually be discovered in this rapidly evolving ®eld of study. 
